12,13-dihydro-6H,7H,14H-naphthyl-[3,4-a]pyrrolo[3,4-c]carbazole-5(5H)one

ID: ALA375085

PubChem CID: 16105511

Max Phase: Preclinical

Molecular Formula: C22H16N2O

Molecular Weight: 324.38

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  O=C1NCc2c1c1c(c3[nH]c4ccccc4c23)CCc2ccccc2-1

Standard InChI:  InChI=1S/C22H16N2O/c25-22-20-16(11-23-22)19-14-7-3-4-8-17(14)24-21(19)15-10-9-12-5-1-2-6-13(12)18(15)20/h1-8,24H,9-11H2,(H,23,25)

Standard InChI Key:  MOAOTAXYKBTMAH-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 25 30  0  0  0  0  0  0  0  0999 V2000
    0.3913   -2.9291    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3010   -3.7482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9643   -4.2340    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1406   -2.5971    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8048   -3.0793    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7156   -3.9021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4706   -4.2414    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.6151   -2.9100    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0234   -3.6290    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2661   -2.9207    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8470   -3.6347    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.2537   -4.3505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0809   -4.3587    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.0916   -2.9226    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.4960   -3.6437    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3208   -3.6531    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7423   -2.9421    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.3328   -2.2202    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5095   -2.2143    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0291   -2.1994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.8541   -2.2047    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1142   -1.4217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4498   -0.9324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    2.7793   -1.4132    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8972   -1.1729    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  2  3  1  0
 10 14  1  0
 11 12  1  0
 12 13  1  0
 13 15  1  0
  3  6  2  0
  6  7  1  0
 14 15  2  0
  7  9  1  0
 15 16  1  0
  8  5  1  0
 16 17  2  0
  1  2  2  0
 17 18  1  0
  5  4  2  0
 18 19  2  0
 19 14  1  0
  8  9  2  0
 20 21  2  0
  9 11  1  0
 10 21  1  0
 20  8  1  0
 10 11  2  0
  4  1  1  0
 21 22  1  0
 22 23  1  0
 23 24  1  0
 24 20  1  0
  5  6  1  0
 22 25  2  0
M  END

Alternative Forms

1. Parent:

   

   ALA375085

   3,13-Diazahexacyclo[14.8.0.0^{2,10}.0^{4,9}.0^{11,15}.0^{17,22}]tetracosa-1(16),2(10),4(9),5,7,11(15),17(22),18,20-nonaen-14-one

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 324.38

Molecular Weight (Monoisotopic): 324.1263

AlogP: 4.33

#Rotatable Bonds: ┄

Polar Surface Area: 44.89

Molecular Species: NEUTRAL

HBA: 1

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 3

HBD (Lipinski): 2

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 13.70

CX Basic pKa: ┄

CX LogP: 4.13

CX LogD: 4.13

Aromatic Rings: 4

Heavy Atoms: 25

QED Weighted: 0.50

Np Likeness Score: 0.73

References

1. Hudkins RL, Johnson NW, Angeles TS, Gessner GW, Mallamo JP..  (2007)  Synthesis and mixed lineage kinase activity of pyrrolocarbazole and isoindolone analogs of (+)K-252a.,  50  (3): [PMID:17266195] [10.1021/jm051074u]

2. Hudkins RL, Diebold JL, Tao M, Josef KA, Park CH, Angeles TS, Aimone LD, Husten J, Ator MA, Meyer SL, Holskin BP, Durkin JT, Fedorov AA, Fedorov EV, Almo SC, Mathiasen JR, Bozyczko-Coyne D, Saporito MS, Scott RW, Mallamo JP..  (2008)  Mixed-lineage kinase 1 and mixed-lineage kinase 3 subtype-selective dihydronaphthyl[3,4-a]pyrrolo[3,4-c]carbazole-5-ones: optimization, mixed-lineage kinase 1 crystallography, and oral in vivo activity in 1-methyl-4-phenyltetrahydropyridine models.,  51  (18): [PMID:18714982] [10.1021/jm8005838]

Source

Source(1):

• Scientific Literature